中国血吸虫病防治杂志 ›› 2021, Vol. 33 ›› Issue (3): 301-.

• 防治管理 • 上一篇    下一篇

我国血吸虫病防治失效专利分析

熊彦红,许学年,郑彬*   

  1. 中国疾病预防控制中心寄生虫病预防控制所(国家热带病研究中心),国家卫生健康委员会寄生虫病原与媒介生物学重点实验室,世界卫生组织热带病合作中心,国家级热带病国际联合研究中心(上海 200025)
  • 出版日期:2021-07-09 发布日期:2021-07-09
  • 作者简介:熊彦红,女,硕士,副研究员。研究方向:卫生健康科研管理与实验室生物安全

Analysis of invalid patents associated with schistosomiasis control filed by Chinese applicants

XIONG Yan⁃Hong, XU Xue⁃Nian, ZHENG Bin*   

  1. National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research); NHC Key Laboratory of Parasite and Vector Biology; WHO Collaborating Centre for Tropical Diseases; National Center for International Research on Tropical Diseases, Shanghai 200025, China
  • Online:2021-07-09 Published:2021-07-09

摘要: [摘要] 在国家知识产权局中国专利数据库、佰腾专利数据库及incoPat数据库中检索我国血吸虫病防治失效专利,并对总体趋势、法律状态、专利类型、专利标引、技术领域分布进行分析挖掘。截至2020年12月30日,我国血吸虫病防治专利累计859件,其中失效专利512件,失效率为59.6%;2018年达到申请与失效专利峰值,有71件专利申请,同年失效专利53件。对511件信息齐全的血吸虫病防治失效专利分析发现,发明专利425件、实用新型专利81件、外观设计专利5件;219件(42.9%)因专利权终止而失效,292件(57.1%)丧失了专利申请权;主要技术点分别为药物(化合物)、基础研究、装置及检测,技术领域主要集中在A61P33、G01N33、C12N15、C07K14及A01N65。我国血吸虫病防治专利失效率较高,建议对血吸虫病防治失效专利技术进行二次开发挖掘,以再次发挥其应用价值。

关键词: 血吸虫病, 专利技术, 失效专利, 中国

Abstract: The invalid patents associated with schistosomiasis control were retrieved in the Chinese Patent Database of China National Intellectual Property Administration, the Baiten database and the incoPat database, and the overall trends, legal status, types, patent indexing and technical fields of all retrieved invalid patents were analyzed. As of December 30, 2020, there were totally 859 patents relating to schistosomiasis control, and 512 were invalid patents, with an invalid rate of 59.6%. The number of patent applications and invalid patents peaked in 2018, including 71 patent applications and 53 invalid patents. Among the 511 schistosomiasis control⁃related invalid patents with complete records, there were 425 invention patents, 81 utility model patents and 5 design patents, and 219 patents (42.9%) were invalid due to the termination of the patented right and 292 (57.1%) due to loss of the right for patent applications. The major technical points included medicines (chemicals), basic research, devices and detections, and the specialized fields were mainly concentrated in A61P33, G01N33, C12N15, C07K14 and A01N65. Our data demonstrate a high invalid rate of patents relating to schistosomiasis control in China. Secondary development and mining of the invalid patents in relation to schistosomiasis are recommended to make use of their values in the national schistosomiasis elimination program of China.

Key words: Schistosomiasis, Patented technology, Invalid patent, China

中图分类号: